Neptune Wellness Solutions, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA64079L3039
USD
0.00
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Neptune Wellness Solutions, Inc. stock-summary
stock-summary
Neptune Wellness Solutions, Inc.
Pharmaceuticals & Biotechnology
Neptune Wellness Solutions Inc. (Neptune) is a diversified and fully integrated health and wellness company. The Company is focused on building a portfolio of natural, plant-based consumer products. Neptune is a provider of turnkey product development and supply chain solutions to business customers across various health and wellness verticals, including legal cannabis and hemp, nutraceuticals and consumer packaged goods. The Company is engaged in cannabis and hemp operation with research, development and commercialization focused on the use of cannabinoids in household products. Its consumer brands include the Forest Remedies and Ocean Remedies brands. Under the Forest Remedies brand, Neptune offers a full line of health and wellness products with and without cannabidiol. The Ocean Remedies brand offers consumers a source of omega-3 supplements. Ocean Remedies krill oil offers high eicosapentaenoic acid, docosahexaenoic acid, phospholipid levels and astaxanthin, a natural antioxidant.
Company Coordinates stock-summary
Company Details
545 Prom du Centropolis Suite 100 , LAVAL QC : H7T 0A3
stock-summary
Tel: 1 450 68722621 617 9566736
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 74 Foreign Institutions (6.05%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. John Moretz
Independent Chairman of the Board
Mr. Michael Cammarata
President, Chief Executive Officer, Director
Mr. Joseph Buaron
Independent Director
Mr. Michael De Geus
Independent Director
Dr. Ronald Denis
Independent Director
Mr. Richard Schottenfeld
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
8 Million
(Quarterly Results - Dec 2023)
Net Profit:
-19 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 0 Million ()

stock-summary
P/E

0

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.80

stock-summary
Return on Equity

172.33%

stock-summary
Price to Book

-0.00